Cambridge Investment Research Advisors
SANA icon

Cambridge Investment Research Advisors’s Sana Biotechnology SANA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79K Buy
22,594
+3,000
+15% +$9.66K ﹤0.01% 3683
2026
Q1 		$56K Buy
+19,594
New +$77.2K ﹤0.01% 3849

Other funds holding SANA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
HI
Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Cambridge Investment Research Advisors's SANA Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Sana Biotechnology (SANA) stake by 15% in Q2 2026, buying an estimated $9.66K and bringing the position to 22,594 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Cambridge Investment Research Advisors first reported a position in SANA in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Cambridge Investment Research Advisors held 22,594 shares of Sana Biotechnology worth $79K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,000 Sana Biotechnology shares in Q2 2026, an estimated $9.66K.
  • Sana Biotechnology made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3683 holding.
  • Cambridge Investment Research Advisors first reported a position in Sana Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.